Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.96 EUR
5.17 B EUR
36.34 B EUR
1.72 B
About Abbott Laboratories
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
FIGI
BBG000H2RDP1
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
ABBOT COVID TRIANGLE BREAKOUTABBOT has been a really bad boy but it eventually put itself in some kind of triangle.
Will it break out? I think so.
PRICE TARGET 103$
STOP LOSS: There is no stop loss!
Abbott TrendsAfter showing a bull trend that lasted several years the stock has moved to bearish teritorry in the past year. During this time the stock price has been range bound between 36 and 46. It is showing resistance at 36 levels. The relative strength of the stock when compared to the S&P 500 is indicatin
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ABL is featured.
Frequently Asked Questions
The current price of ABL is 113.08 EUR — it has decreased by −0.51% in the past 24 hours. Watch ABBOTT LABS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ABBOTT LABS stocks are traded under the ticker ABL.
ABL stock has risen by 1.63% compared to the previous week, the month change is a 6.15% rise, over the last year ABBOTT LABS has showed a 21.08% increase.
We've gathered analysts' opinions on ABBOTT LABS future price: according to them, ABL price has a max estimate of 137.53 EUR and a min estimate of 107.99 EUR. Watch ABL chart and read a more detailed ABBOTT LABS stock forecast: see what analysts think of ABBOTT LABS and suggest that you do with its stocks.
ABL stock is 1.14% volatile and has beta coefficient of 0.11. Track ABBOTT LABS stock price on the chart and check out the list of the most volatile stocks — is ABBOTT LABS there?
Today ABBOTT LABS has the market capitalization of 193.65 B, it has increased by 1.81% over the last week.
Yes, you can track ABBOTT LABS financials in yearly and quarterly reports right on TradingView.
ABBOTT LABS is going to release the next earnings report on Jan 22, 2025. Keep track of upcoming events with our Earnings Calendar.
ABL earnings for the last quarter are 1.09 EUR per share, whereas the estimation was 1.08 EUR resulting in a 0.65% surprise. The estimated earnings for the next quarter are 1.27 EUR per share. See more details about ABBOTT LABS earnings.
ABBOTT LABS revenue for the last quarter amounts to 9.55 B EUR, despite the estimated figure of 9.48 B EUR. In the next quarter, revenue is expected to reach 10.45 B EUR.
ABL net income for the last quarter is 1.47 B EUR, while the quarter before that showed 1.21 B EUR of net income which accounts for 21.64% change. Track more ABBOTT LABS financial stats to get the full picture.
Yes, ABL dividends are paid quarterly. The last dividend per share was 0.50 EUR. As of today, Dividend Yield (TTM)% is 1.87%. Tracking ABBOTT LABS dividends might help you take more informed decisions.
ABBOTT LABS dividend yield was 1.89% in 2023, and payout ratio reached 63.81%. The year before the numbers were 1.75% and 49.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 28, 2024, the company has 114.00 K employees. See our rating of the largest employees — is ABBOTT LABS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT LABS EBITDA is 8.96 B EUR, and current EBITDA margin is 24.13%. See more stats in ABBOTT LABS financial statements.
Like other stocks, ABL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LABS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBOTT LABS technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBOTT LABS stock shows the strong buy signal. See more of ABBOTT LABS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.